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Cystinosis Presenting with Findings of Bartter Syndrome
Case Report
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Introduction
Cystinosis is caused by a defect in transport of cystine
across the lysosomal membrane, due to defective function of
the lysosomal membrane protein cystinosin, resulting from
mutations of the cystinosin gene (CTNS) (1).  This gene resides
on chromosome 17p13 and has 12 exons, the last 10 of 
which code for cystinosin. There are three variants of clinically
recognizable cystinosis, namely, the infantile (nephropathic)
form, the juvenile (intermediate) form and the adult (benign)
form (2,3).
The infantile nephropathic cystinosis is a rare form 
occurring in 1:100 000-200 000 of live births (4). The defective
transport of cystine across the lysosomal membrane causes
an accumulation of this aminoacid in cells, affecting the 
functions of organs such as kidneys, eyes and the thyroid
gland (3,4,5).
Symptoms in nephropathic cystinosis appear within the
first 3-12 months of life. These patients typically present with
symptoms of severe fluid and electrolyte disturbance, renal
Fanconi syndrome, vitamin D-resistant rickets, metabolic 
acidosis, growth failure, and photophobia. The clinical state
progresses to end-stage renal failure (ESRD) by the end of the
first decade of life if left untreated (6,7).
This report describes a child who presented with growth
retardation and was initially diagnosed as Bartter syndrome,
but subsequently as cystinosis. 
Case Report
A five-year-old boy was referred to our department 
for evaluation of failure to thrive, intermittent high fever, 
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term with a birth weight of 3500 g. Pregnancy and delivery
were reported as uncomplicated. There was no history of 
persistent diarrhea and vomiting. The parents were 
first-degree relatives.   The patient was admitted for further
evaluation and treatment of his metabolic alkalosis, polyuria
and hypokalemia. On physical examination, his weight was 11
kg (<3rd  percentile) and his height was 83 cm (<3rd 
percentile). Blood pressure was 90/60 mmHg (normal for
age), pulse rate 104 beats/min, and temperature 36.6°C. He
had blond hair and fair skin and a sluggish appearance. Frontal
bossing, carious teeth, and O-shaped deformity of the lower
extremities were noted. Signs of moderate dehydration such
as dry oral mucosa, sunken eyes, and decreased skin turgor
were present. Neurological and mental status evaluations
were reported as normal.
Whole blood count was normal (Hb 12 g/dL, Htc 37%,
WBC 9,600/mm3, platelets 185 000/mm3). Serum sodium
level was 118 mEq/L, potassium 2.0 mEq/L, chloride 78
mEq/L.  Blood urea nitrogen was 32 mg/dL, creatinine 1.4
mg/dL, calcium 9.3 mg/dL, phosphorus 2.7 mg/dL, alkaline
phosphatase 400 U/L, ALT 32 U/L, AST 28 U/L and glucose 93
mg/dL. Urinalysis showed a specific gravity of 1002 and pH
level of 7.0. Glucosuria (+)  and proteinuria (++) were present.
Microscopic examination of the urine sediment was normal.
Venous blood gas analysis revealed values consistent with
metabolic alkalosis (pH 7.51, pCO2 33 mm Hg, bicarbonate
28.8 mmol/L). Twenty-four-hour urine volume was 4200
mL/m2 /day (7.5 mL/kg/day), indicating polyuria. Tubular 
reabsorption of phosphorus was 78% (90-110%).  Twenty-
four-hour urinary calcium excretion was 12.5 mg/kg (normal
rate: <4 mg/kg/day). Blood renin and aldosterone levels were
increased (66 mg/mL and 1020 ng/dL, respectively).
Generalized aminoaciduria was detected. 
Based on the presence of metabolic alkalosis,
hypokalemia, hyponatremia, hypochloremia and high renin
and aldosterone levels, a diagnosis of Bartter syndrome was
made and the patient was started on a treatment regimen
consisting of sodium chloride, potassium citrate,
indomethacin, hydrochlorothiazide and amiloride. At this time,
the sweat chloride level was normal (34 mEq/L). Radiologic
examination of the left wrist showed active rachitic changes.
The serum level of 25(OH)D was 9.3 ng/mL (<11 ng/mL) and
an anterio-posterior X-ray of the left wrist was consistent 
with rickets (Figure 1). Renal ultrasonography findings were
normal. Calcitriol treament in a dose of 25 μ/day was started. 
One month later, the patient developed metabolic 
acidosis with a high urinary pH (pH 6). Presence of proteinuria,
aminoaciduria, glucosuria, phosphaturia and hypercalciuria
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Figure 1. The metaphyses are frayed, cupped and splayed in the
distal radius and ulna in rickets
Figure 2. Slit-lamp examination of the cornea showing cystine crystal
depositswas suggestive of proximal renal tubular acidosis. Blood renin
and aldosterone levels were retested and found to be normal.
The treatment schedule was changed to a combination of
sodium bicarbonate, hydrochlorothiazide-amiloride, potassium
citrate, indomethacin, Joule’s solution and Shohl’s solution. 
An overall evaluation of the clinical and laboratory findings
of the patient led to a probable diagnosis of cystinosis. 
The diagnosis was confirmed by slit-lamp examination of the
cornea showing cystine crystal deposits (Figure 2). 
Thyroid function tests were within normal range. Renal 
ultrasonography showed both kidneys to be normal. 
The patient is at present being treated with 
1,25-dihydroxycholecalciferol, sodium bicarbonate, potassium,
Shohl’s solution, Joule’s solution, cysteamine (Cystagon  50
mg/kg per day in four doses) and carnitine. The patient gained
1200 g in weight within one month of the initiation of this 
regimen. The polyuria has improved and serum electrolyte
levels have returned to normal.
Discussion
Cystinosis is a genetic disorder of autosomal recessive
inheritance due to defective lysosomal cystine transport 
leading to excessive intracellular cystine accumulation. The
proximal tubule is very sensitive to cystine storage and these
patients manifest the features of the Fanconi syndrome. The
typical clinical picture is renal Fanconi syndrome in most
infants with cystinosis (6,7). In this form of the classic 
childhood nephropathy, patients appear clinically normal at
birth. However, depending on the degree of the disease,
tubulopathy characterized by metabolic acidosis, glucosuria,
aminoaciduria, bicarbonaturia, phosphaturia, hypokalemia
develops in the first decade of life and these signs are 
mostly consistent with renal Fanconi syndrome. The typical
presentation of these patients is proximal renal tubular 
acidosis (7,8). However, some patients diagnosed as 
cystinosis may present initially with metabolic alkalosis
(8,9,10,11,12,13). In our patient, although the initial laboratory
findings were suggestive of renal tubular Fanconi syndrome,
the levels of blood gases were compatible with metabolic
alkalosis. The patient’s serum renin and aldosterone levels
were above normal, serum sodium and chloride levels were
low, metabolic alkalosis was present. Excretion of urinary
sodium and chloride was increased. Based on these findings,
Bartter syndrome was the initially considered diagnosis.
During follow-up, in a polarized eye examination made for the
evaluation of the patient's photophobia, cystine crystals were
detected. Approximately one month later, the nature of the
levels of the blood gas composition changed and became
compatible with acidosis (pH: 7.2; HCO3: 10 mEq/L; pCO2: 25
mEq/L) Urine pH was high. The reason why cystinosis pres-
ents with metabolic alkalosis, simulating the findings of
Bartter syndrome, is still unknown. Tubular dysfunction 
resulting from cystine accumulation may cause these 
findings, but the pathogenesis of intralysosomal cystine 
accumulation leading to the dysfunction of the proximal
tubule has not yet been resolved. Yildiz et al (13) reported a
16-month-old male patient presenting with signs of Bartter
syndrome. This patient also, later on, was diagnosed as 
cystinosis.  To explain these findings, the authors speculated
that a sodium-dependent transtubular transport defect causes
increased distal tubular delivery of sodium, which in turn leads
to an enhanced exchange of sodium for potassium and 
hydrogen ion, perpetuating a contraction alkalosis. In some
studies, hyperplasia of the juxtaglomerular apparatus with 
elevated levels of renin and aldosterone due to hyponatremia
was reported in patients with cystinosis and these findings
were attributed to an increased exchange of sodium for
hydrogen and potassium ion caused by the hyperreninemia
and hyperaldosteronism (8,13). In our patient, serum sodium
level was low. Renin and aldosterone levels were above 
normal initially and decreased to normal on follow-up.  
A definite diagnosis of cystinosis can be made 
by showing increased levels of cystine in leukocytes 
or fibroblasts (14). The diagnosis can also be reached 
by demonstration of cystine crystals in tissues such as bone
marrow, lymph nodes, or conjunctiva (14,15). In our patient
also, the final diagnosis was made by showing cystine 
crystals in the ocular tissue. 
Cysteamine therapy constitutes the mainstay of 
treatment of cystinosis, supported by measures to improve
water-electrolyte and acid-base disturbances. In some cases,
indomethacin is used to reduce the loss of water, sodium and
potassium by the renal tubules. Vitamin D is used to correct
the hypocalcemia and carnitine therapy is instituted to keep
the reduced levels of carnitine within the normal range. 
In conclusion, as also demonstrated in our patient, 
cystinosis can initially present with the laboratory findings of
Bartter syndrome. New studies are needed to clarify the
etiopathogenesis of this association. 
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